首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
THE CHALLENGES OF OUTCOMES-BASED REIMBURSEMENT FOR ADVANCED THERAPY MEDICINAL PRODUCTS IN EUROPE
被引:0
|
作者
:
Wallace, M.
论文数:
0
引用数:
0
h-index:
0
机构:
Labcorp Drug Dev, London, England
Labcorp Drug Dev, London, England
Wallace, M.
[
1
]
Redman, N.
论文数:
0
引用数:
0
h-index:
0
机构:
Labcorp Drug Dev, London, England
Labcorp Drug Dev, London, England
Redman, N.
[
1
]
机构
:
[1]
Labcorp Drug Dev, London, England
来源
:
VALUE IN HEALTH
|
2022年
/ 25卷
/ 12期
关键词
:
D O I
:
暂无
中图分类号
:
F [经济];
学科分类号
:
02 ;
摘要
:
HPR106
引用
收藏
页码:S251 / S251
页数:1
相关论文
共 50 条
[1]
REIMBURSEMENT OF ADVANCED THERAPY MEDICINAL PRODUCTS IN EUROPE
Hanna, E.
论文数:
0
引用数:
0
h-index:
0
机构:
Creat Ceut, Paris, France
Creat Ceut, Paris, France
Hanna, E.
Marre, C.
论文数:
0
引用数:
0
h-index:
0
机构:
Creat Ceut, Paris, France
Creat Ceut, Paris, France
Marre, C.
Toumi, M.
论文数:
0
引用数:
0
h-index:
0
机构:
Aix Marseille Univ, Marseille, France
Creat Ceut, Paris, France
Toumi, M.
VALUE IN HEALTH,
2018,
21
: S202
-
S203
[2]
THE REIMBURSEMENT STATUS OF ADVANCED THERAPY MEDICINAL PRODUCTS IN EUROPE
Hanna, E.
论文数:
0
引用数:
0
h-index:
0
机构:
Creativ Ceut, Paris, France
Creativ Ceut, Paris, France
Hanna, E.
Marre, C.
论文数:
0
引用数:
0
h-index:
0
机构:
Creativ Ceut, Paris, France
Creativ Ceut, Paris, France
Marre, C.
Toumi, M.
论文数:
0
引用数:
0
h-index:
0
机构:
Aix Marseille Univ, Marseille, France
Creativ Ceut, Paris, France
Toumi, M.
VALUE IN HEALTH,
2019,
22
: S428
-
S428
[3]
Linking Reimbursement to Patient Benefits for Advanced Therapy Medicinal Products and Other High-Cost Innovations: Policy Recommendations for Outcomes-Based Agreements in Europe
Avsar, Tuba Saygin
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Inst Hlth & Care Excellence NICE, Sci Policy & Res Program, Manchester, England
Natl Inst Hlth & Care Excellence NICE, Sci Policy & Res Program, Manchester, England
Avsar, Tuba Saygin
Elvidge, Jamie
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Inst Hlth & Care Excellence NICE, Sci Policy & Res Program, Manchester, England
Natl Inst Hlth & Care Excellence NICE, Sci Policy & Res Program, Manchester, England
Elvidge, Jamie
Hawksworth, Claire
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Inst Hlth & Care Excellence NICE, Sci Policy & Res Program, Manchester, England
Natl Inst Hlth & Care Excellence NICE, Sci Policy & Res Program, Manchester, England
Hawksworth, Claire
Kenny, Juliet
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Inst Hlth & Care Excellence NICE, Sci Policy & Res Program, Manchester, England
Natl Inst Hlth & Care Excellence NICE, Sci Policy & Res Program, Manchester, England
Kenny, Juliet
Nemeth, Bertalan
论文数:
0
引用数:
0
h-index:
0
机构:
Syreon Res Inst, Budapest, Hungary
Natl Inst Hlth & Care Excellence NICE, Sci Policy & Res Program, Manchester, England
Nemeth, Bertalan
论文数:
引用数:
h-index:
机构:
Callenbach, Marcelien
Ringkvist, Johanna
论文数:
0
引用数:
0
h-index:
0
机构:
Dent & Pharmaceut Benefits Agcy TLV, Stockholm, Sweden
Natl Inst Hlth & Care Excellence NICE, Sci Policy & Res Program, Manchester, England
Ringkvist, Johanna
Dawoud, Dalia
论文数:
0
引用数:
0
h-index:
0
机构:
Natl Inst Hlth & Care Excellence NICE, Sci Policy & Res Program, Manchester, England
Natl Inst Hlth & Care Excellence NICE, Sci Policy & Res Program, Manchester, England
Dawoud, Dalia
VALUE IN HEALTH,
2024,
27
(11)
: 1497
-
1506
[4]
CHALLENGES AND FUTURE PERSPECTIVES ON THE REIMBURSEMENT OF ADVANCED THERAPY MEDICINAL PRODUCTS
Rothwell, S.
论文数:
0
引用数:
0
h-index:
0
机构:
Evidera, London, England
Evidera, London, England
Rothwell, S.
January, D.
论文数:
0
引用数:
0
h-index:
0
机构:
Evidera, Bethesda, MD USA
Evidera, London, England
January, D.
Duda, M.
论文数:
0
引用数:
0
h-index:
0
机构:
Evidera, San Francisco, CA USA
Evidera, London, England
Duda, M.
Gardner, K.
论文数:
0
引用数:
0
h-index:
0
机构:
Evidera, London, England
Evidera, London, England
Gardner, K.
Michel, S.
论文数:
0
引用数:
0
h-index:
0
机构:
Evidera, London, England
Evidera, London, England
Michel, S.
VALUE IN HEALTH,
2017,
20
(09)
: A705
-
A705
[5]
Access Challenges of Advanced Therapy Medicinal Products in Europe
Szulc, E.
论文数:
0
引用数:
0
h-index:
0
机构:
LatticePoint Consulting, Geneva, Switzerland
LatticePoint Consulting, Geneva, Switzerland
Szulc, E.
Tschumi, B.
论文数:
0
引用数:
0
h-index:
0
机构:
LatticePoint Consulting, Geneva, Switzerland
LatticePoint Consulting, Geneva, Switzerland
Tschumi, B.
Pennese, N.
论文数:
0
引用数:
0
h-index:
0
机构:
LatticePoint Consulting, Geneva, Switzerland
LatticePoint Consulting, Geneva, Switzerland
Pennese, N.
Lecureuil, C.
论文数:
0
引用数:
0
h-index:
0
机构:
LatticePoint Consulting, Geneva, Switzerland
LatticePoint Consulting, Geneva, Switzerland
Lecureuil, C.
Robbins, S.
论文数:
0
引用数:
0
h-index:
0
机构:
LatticePoint Consulting, Geneva, Switzerland
LatticePoint Consulting, Geneva, Switzerland
Robbins, S.
VALUE IN HEALTH,
2022,
25
(12)
: S336
-
S336
[6]
Europe's Advanced Therapy Medicinal Products: chances and challenges
Mertsching, Heike
论文数:
0
引用数:
0
h-index:
0
机构:
Interfacial Engn & Biotechnol IGB, Fraunhofer Inst, D-70569 Stuttgart, Germany
Schillerhoehe Hosp, D-70839 Gerlingen, Germany
Mertsching, Heike
Walles, Thorsten
论文数:
0
引用数:
0
h-index:
0
机构:
Schillerhoehe Hosp, D-70839 Gerlingen, Germany
Schillerhoehe Hosp, D-70839 Gerlingen, Germany
Walles, Thorsten
EXPERT REVIEW OF MEDICAL DEVICES,
2009,
6
(02)
: 109
-
110
[7]
REIMBURSEMENT PATHWAY FOR ADVANCED THERAPY MEDICINAL PRODUCTS IN BULGARIA
Djambazov, S.
论文数:
0
引用数:
0
h-index:
0
机构:
Med Univ Pleven, Sofia 23, Bulgaria
Med Univ Pleven, Sofia 23, Bulgaria
Djambazov, S.
Vutova, Y.
论文数:
0
引用数:
0
h-index:
0
机构:
HTA Ltd, Sofia 23, Bulgaria
Med Univ Pleven, Sofia 23, Bulgaria
Vutova, Y.
Dacheva, A.
论文数:
0
引用数:
0
h-index:
0
机构:
HTA Ltd, Sofia 23, Bulgaria
Med Univ Pleven, Sofia 23, Bulgaria
Dacheva, A.
Koleva-Kolarova, R.
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Oxford, Oxford, England
Med Univ Pleven, Sofia 23, Bulgaria
Koleva-Kolarova, R.
Encheva-Malinova, M.
论文数:
0
引用数:
0
h-index:
0
机构:
HTA Ltd, Sofia 22, Bulgaria
Med Univ Pleven, Sofia 23, Bulgaria
Encheva-Malinova, M.
VALUE IN HEALTH,
2022,
25
(07)
: S472
-
S472
[8]
THE USE OF PATIENT REPORTED OUTCOMES IN AIDING THE REIMBURSEMENT DECISIONS OF ADVANCED MEDICINAL THERAPY PRODUCTS
Young, J.
论文数:
0
引用数:
0
h-index:
0
机构:
Cytel Inc, Berlin, Germany
Cytel Inc, Berlin, Germany
Young, J.
Bolzani, A.
论文数:
0
引用数:
0
h-index:
0
机构:
Cytel Inc, Berlin, Germany
Cytel Inc, Berlin, Germany
Bolzani, A.
VALUE IN HEALTH,
2022,
25
(12)
: S327
-
S327
[9]
The Challenges of Outcomes-Based Contract Implementation for Medicines in Europe
Bohm, Natalie
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Ltd, Walton Oaks,Dorking Rd, Tadworth KT20 7NS, England
Pfizer Ltd, Walton Oaks,Dorking Rd, Tadworth KT20 7NS, England
Bohm, Natalie
Bermingham, Sarah
论文数:
0
引用数:
0
h-index:
0
机构:
Symmetron Ltd, London, England
Pfizer Ltd, Walton Oaks,Dorking Rd, Tadworth KT20 7NS, England
Bermingham, Sarah
Grimsey Jones, Frank
论文数:
0
引用数:
0
h-index:
0
机构:
Symmetron Ltd, London, England
Pfizer Ltd, Walton Oaks,Dorking Rd, Tadworth KT20 7NS, England
Grimsey Jones, Frank
Goncalves-Bradley, Daniela C.
论文数:
0
引用数:
0
h-index:
0
机构:
Symmetron Ltd, London, England
Pfizer Ltd, Walton Oaks,Dorking Rd, Tadworth KT20 7NS, England
Goncalves-Bradley, Daniela C.
Diamantopoulos, Alex
论文数:
0
引用数:
0
h-index:
0
机构:
Symmetron Ltd, London, England
Pfizer Ltd, Walton Oaks,Dorking Rd, Tadworth KT20 7NS, England
Diamantopoulos, Alex
Burton, Jessica R.
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Ltd, Walton Oaks,Dorking Rd, Tadworth KT20 7NS, England
Pfizer Ltd, Walton Oaks,Dorking Rd, Tadworth KT20 7NS, England
Burton, Jessica R.
论文数:
引用数:
h-index:
机构:
Laing, Hamish
PHARMACOECONOMICS,
2022,
40
(01)
: 13
-
29
[10]
The Challenges of Outcomes-Based Contract Implementation for Medicines in Europe
Natalie Bohm
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Limited,Value
Natalie Bohm
Sarah Bermingham
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Limited,Value
Sarah Bermingham
Frank Grimsey Jones
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Limited,Value
Frank Grimsey Jones
Daniela C. Gonçalves-Bradley
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Limited,Value
Daniela C. Gonçalves-Bradley
Alex Diamantopoulos
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Limited,Value
Alex Diamantopoulos
Jessica R. Burton
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Limited,Value
Jessica R. Burton
Hamish Laing
论文数:
0
引用数:
0
h-index:
0
机构:
Pfizer Limited,Value
Hamish Laing
PharmacoEconomics,
2022,
40
: 13
-
29
←
1
2
3
4
5
→